Study in ALS With Abatacept & IL-2

Clinical trial NCT06307301 · COMPLETED

Trial details

NCT number: NCT06307301
Sponsor: The Methodist Hospital Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-10-28
Primary completion: 2022-12-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.